Exodus Point Capital Management, LP Pulmonx Corp Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
A detailed history of Exodus Point Capital Management, LP transactions in Pulmonx Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 48,047 shares of LUNG stock, worth $430,501. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,047
Previous 75,246
36.15%
Holding current value
$430,501
Previous $624,000
47.76%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$49.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$27.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$20.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.8 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $334M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...